Corona Remedies Declares Unaudited Q1 FY27 Financial Results

Corona Remedies Ltd announced the outcome of its Board Meeting held today, wherein the Board approved the unaudited standalone and consolidated financial results for the first quarter and three months ended June 30, 2026. The company also approved the limited review reports for the same period. These results will be published in an advertisement as per listing regulations and will be available on the company's website. The Board meeting commenced at 3:00 p.m. and concluded at 4:00 p.m.